<?xml version="1.0" encoding="ISO-8859-1" ?><rss version="2.0"><channel><link>http://www.ir.dermasciences.com/profiles/investor/RSSFeeds.asp?BzID=1109</link><title>DERMA SCiENCES News powered by SmartWire</title><description>SmartWire News</description><image><title>SmartWire News</title><url>http://www.b2i.cc/logos/1109/control_logo.jpg</url><link>http://www.ir.dermasciences.com/profiles/investor/RSSFeeds.asp?BzID=1109</link></image><ttl>10</ttl><language>en</language><item><guid isPermaLink="true">http://www.ir.dermasciences.com/irpass.asp?BzID=1109&amp;to=rl&amp;ResLibraryID=40228&amp;c=440&amp;l=1</guid><title><![CDATA[Derma Sciences Novel XTRASORB&#174; HCS Dressings Receive Federal Reimbursement Codes; Join Foam and Classic Dressings for Complete Coverage of Product Category]]></title><pubDate>Thu, 2 Sep 2010 11:56:00 </pubDate><description><![CDATA[Derma Sciences, Inc. (Nasdaq: DSCI), a medical device and 
      pharmaceutical company focused on advanced wound care, announces that 
      all five products in its novel line of XTRASORB&#174; HCS Dressings have 
      received Healthcare Common Procedural Coding System (HCPCS) codes. These 
      codes – A6234 through A6238 – were awarded by the Centers for Medicare 
      and Medicaid Services (CMS), and allow healthcare providers to bill for 
      the dressings beginning immediately....]]></description><link>http://www.ir.dermasciences.com/irpass.asp?BzID=1109&amp;to=rl&amp;ResLibraryID=40228&amp;c=440&amp;l=1</link></item><item><guid isPermaLink="true">http://www.ir.dermasciences.com/irpass.asp?BzID=1109&amp;to=rl&amp;ResLibraryID=39939&amp;c=440&amp;l=1</guid><title><![CDATA[Derma Sciences Second Quarter Results Feature Net Sales Up 14%; Advanced Wound Care Sales Up 47%]]></title><pubDate>Fri, 13 Aug 2010 07:00:00 </pubDate><description><![CDATA[
      Derma Sciences, Inc. (Nasdaq: DSCI), a medical device and pharmaceutical 
      company focused on advanced wound care, today reported financial and 
      operating results for the three and six months ended June 30, 2010. 
      Highlights of the second quarter of 2010 and recent weeks include:
    
        Net sales increased 14% to $13.2 million from $11.6 million in the 
        second quarter of 2009.
      
        Advanced wound care sales were $2.6 million, up 47% from $1.7...]]></description><link>http://www.ir.dermasciences.com/irpass.asp?BzID=1109&amp;to=rl&amp;ResLibraryID=39939&amp;c=440&amp;l=1</link></item><item><guid isPermaLink="true">http://www.ir.dermasciences.com/irpass.asp?BzID=1109&amp;to=rl&amp;ResLibraryID=39820&amp;c=440&amp;l=1</guid><title><![CDATA[Derma Sciences Announces Second Quarter 2010 Results Conference Call]]></title><pubDate>Mon, 9 Aug 2010 08:45:00 </pubDate><description><![CDATA[
      Derma Sciences, Inc. (Nasdaq:DSCI), a medical device and pharmaceutical 
      company focused on advanced wound care, will hold a conference call on 
      August 13, 2010 to discuss the financial results for the second quarter 
      ended June 30, 2010. In addition, management will provide a business 
      update and a discussion on recent and upcoming milestones.
    
      The conference call is scheduled to begin at 11:00 a.m. EDT (Eastern 
      Daylight Time). The results will...]]></description><link>http://www.ir.dermasciences.com/irpass.asp?BzID=1109&amp;to=rl&amp;ResLibraryID=39820&amp;c=440&amp;l=1</link></item><item><guid isPermaLink="true">http://www.ir.dermasciences.com/irpass.asp?BzID=1109&amp;to=rl&amp;ResLibraryID=39313&amp;c=440&amp;l=1</guid><title><![CDATA[Webcast Alert: Derma Sciences, Inc. Announces the LHA Life Sciences &amp; Med Tech Day 2010 Presentation]]></title><pubDate>Wed, 14 Jul 2010 17:34:00 </pubDate><description><![CDATA[NEW YORK, July 14 /PRNewswire-FirstCall/ -- Derma Sciences, Inc. (Nasdaq: DSCI) announces the following Webcast:What:LHA Life Sciences &amp; Med Tech Day 2010 PresentationWhen:July 20, 2010 @ 11:30 AM EasternWhere:http://www.investorcalendar.com/ClientPage.asp?ID=160488How:Live over the Internet -- Simply log on to the web at the address above.Contact:Cheryl Palazzo, 212-838-3777, cpalazzo@lhai.comIf you are unable to participate during the live webcast, the call will be available for replay at...]]></description><link>http://www.ir.dermasciences.com/irpass.asp?BzID=1109&amp;to=rl&amp;ResLibraryID=39313&amp;c=440&amp;l=1</link></item><item><guid isPermaLink="true">http://www.ir.dermasciences.com/irpass.asp?BzID=1109&amp;to=rl&amp;ResLibraryID=39237&amp;c=440&amp;l=1</guid><title><![CDATA[Derma Sciences Submits 510(k) Application for MEDIHONEY Gel, Reaches Goal of 20-Person U.S. Field Sales Force]]></title><pubDate>Fri, 9 Jul 2010 07:30:00 </pubDate><description><![CDATA[
      Derma Sciences, Inc. (NASDAQ: DSCI), a medical device and pharmaceutical 
      company focused on advanced wound care, announces the achievement of 
      regulatory and commercial milestones.
    
      Late last week the Company submitted a 510(k) application to the U.S. 
      Food and Drug Administration (FDA) for MEDIHONEY&#174; Gel Wound &amp; Burn 
      Dressing. This latest MEDIHONEY line extension is dispensed from a tube 
      and is comprised of Active Manuka (Leptospermum)...]]></description><link>http://www.ir.dermasciences.com/irpass.asp?BzID=1109&amp;to=rl&amp;ResLibraryID=39237&amp;c=440&amp;l=1</link></item><item><guid isPermaLink="true">http://www.ir.dermasciences.com/irpass.asp?BzID=1109&amp;to=rl&amp;ResLibraryID=38994&amp;c=440&amp;l=1</guid><title><![CDATA[Derma Sciences Added to Russell Microcap Index]]></title><pubDate>Mon, 28 Jun 2010 07:25:00 </pubDate><description><![CDATA[
      Derma Sciences, Inc. (Nasdaq: DSCI), a medical device and pharmaceutical 
      company focused on advanced wound care, announced today that the 
      Company's common stock has been added to the Russell Microcap&#174; Index 
      posted by Russell Investments on www.russell.com. 
      These changes went into effect after the close of trading on Friday, 
      June 25, 2010.
    
      'Inclusion in this index represents an important step in the growth of 
      Derma Sciences and we...]]></description><link>http://www.ir.dermasciences.com/irpass.asp?BzID=1109&amp;to=rl&amp;ResLibraryID=38994&amp;c=440&amp;l=1</link></item><item><guid isPermaLink="true">http://www.ir.dermasciences.com/irpass.asp?BzID=1109&amp;to=rl&amp;ResLibraryID=38882&amp;c=440&amp;l=1</guid><title><![CDATA[Derma Sciences Announces Issuance of Second U.S. Patent Related to MEDIHONEY Alginate Dressing]]></title><pubDate>Tue, 22 Jun 2010 07:30:00 </pubDate><description><![CDATA[Further Strengthens Intellectual Property on Company's Lead Product
      Derma Sciences, Inc. (Nasdaq:DSCI), a medical device and pharmaceutical 
      company focused on advanced wound care, announces that the U.S. Patent 
      and Trademark Office has issued patent No. 7,714,183 related to the 
      Company's MEDIHONEY&#174; Calcium Alginate Dressing.
    
      This is the second patent granted in the U.S. covering Derma Sciences' 
      line of proprietary honey-based wound dressings....]]></description><link>http://www.ir.dermasciences.com/irpass.asp?BzID=1109&amp;to=rl&amp;ResLibraryID=38882&amp;c=440&amp;l=1</link></item><item><guid isPermaLink="true">http://www.ir.dermasciences.com/irpass.asp?BzID=1109&amp;to=rl&amp;ResLibraryID=38593&amp;c=440&amp;l=1</guid><title><![CDATA[Derma Sciences Awarded HCPCS Code for BIOGUARD(TM) Conforming Bandage]]></title><pubDate>Wed, 9 Jun 2010 08:17:00 </pubDate><description><![CDATA[Code Allows Bandage to Be Reimbursed by Medicare and Most Private Health Insurance CompaniesPRINCETON, N.J., June 9 /PRNewswire-FirstCall/ -- Derma Sciences, Inc. (Nasdaq: DSCI), a medical device and pharmaceutical company focused on advanced wound care, has been awarded the Healthcare Common Procedural Coding System (HCPCS) code A6266 for its BIOGUARD&trade; Conforming Bandage. This code, which was awarded by the Centers for Medicare and Medicaid Services (CMS), is the same as that assigned...]]></description><link>http://www.ir.dermasciences.com/irpass.asp?BzID=1109&amp;to=rl&amp;ResLibraryID=38593&amp;c=440&amp;l=1</link></item><item><guid isPermaLink="true">http://www.ir.dermasciences.com/irpass.asp?BzID=1109&amp;to=rl&amp;ResLibraryID=38490&amp;c=440&amp;l=1</guid><title><![CDATA[Derma Sciences to Present at the Noble Financial Equity Conference on June 8]]></title><pubDate>Thu, 3 Jun 2010 14:33:00 </pubDate><description><![CDATA[PRINCETON, N.J., June 3 /PRNewswire-FirstCall/ -- Derma Sciences, Inc. (Nasdaq: DSCI), a medical device and pharmaceutical company focused on advanced wound care, today announced that Edward J. Quilty, Chairman and CEO, will make a presentation regarding the business strategy and financial outlook of the Company at the Noble Financial Sixth Annual Equity Conference at 12:30pm EDT on June 8, 2010, at the Hard Rock Hotel in Hollywood, Florida.The presentation will be webcast LIVE featuring...]]></description><link>http://www.ir.dermasciences.com/irpass.asp?BzID=1109&amp;to=rl&amp;ResLibraryID=38490&amp;c=440&amp;l=1</link></item><item><guid isPermaLink="true">http://www.ir.dermasciences.com/irpass.asp?BzID=1109&amp;to=rl&amp;ResLibraryID=38034&amp;c=440&amp;l=1</guid><title><![CDATA[Derma Sciences Announces First Quarter 2010 Results]]></title><pubDate>Thu, 13 May 2010 09:00:00 </pubDate><description><![CDATA[PRINCETON, N.J., May 13 /PRNewswire-FirstCall/ -- Derma Sciences, Inc. (Nasdaq: DSCI), a specialty medical device/pharmaceutical company focused on advanced wound care, reported financial and operating results today for the three months ended March 31, 2010.Highlights for First Quarter 2010:Net sales increased 23% to $12,844,382 versus $10,431,891 in first quarter 2009.  Advanced wound care sales increased 70% to $2,281,564 versus $1,346,223 in first quarter 2009.Net loss was reduced to...]]></description><link>http://www.ir.dermasciences.com/irpass.asp?BzID=1109&amp;to=rl&amp;ResLibraryID=38034&amp;c=440&amp;l=1</link></item><item><guid isPermaLink="true">http://www.ir.dermasciences.com/irpass.asp?BzID=1109&amp;to=rl&amp;ResLibraryID=38000&amp;c=440&amp;l=1</guid><title><![CDATA[Derma Sciences Opens First International Office in London]]></title><pubDate>Wed, 12 May 2010 07:49:00 </pubDate><description><![CDATA[PRINCETON, N.J., May 12 /PRNewswire-FirstCall/ -- Derma Sciences, Inc. (Nasdaq: DSCI), a medical device and pharmaceutical company focused on advanced wound care, today announced that it has established an international subsidiary, Derma Sciences Europe Limited, and will soon be opening an office near London, England.  "Europe represents a substantial growth opportunity for Derma Sciences and is a logical next step in expanding our sales efforts," said Edward J. Quilty, Derma Sciences' Chairman...]]></description><link>http://www.ir.dermasciences.com/irpass.asp?BzID=1109&amp;to=rl&amp;ResLibraryID=38000&amp;c=440&amp;l=1</link></item><item><guid isPermaLink="true">http://www.ir.dermasciences.com/irpass.asp?BzID=1109&amp;to=rl&amp;ResLibraryID=37988&amp;c=440&amp;l=1</guid><title><![CDATA[Derma Sciences to Present at the Rodman &amp; Renshaw Annual Global Investment Conference]]></title><pubDate>Tue, 11 May 2010 12:56:00 </pubDate><description><![CDATA[PRINCETON, N.J., May 11 /PRNewswire-FirstCall/ -- Derma Sciences, Inc. (Nasdaq:  DSCI), a medical device and pharmaceutical company focused on advanced wound care, will present at the Rodman &amp; Renshaw Annual Global Investment Conference. The Conference will take place May 16 – 18, 2010 at the Grosvenor House Hotel in London, UK.Edward J. Quilty, Chairman and CEO of Derma Sciences will present on Tuesday, May 18, 2010 at 10:40 am BST (5:40 am ET) in the Spencer Suite. Additional information...]]></description><link>http://www.ir.dermasciences.com/irpass.asp?BzID=1109&amp;to=rl&amp;ResLibraryID=37988&amp;c=440&amp;l=1</link></item><item><guid isPermaLink="true">http://www.ir.dermasciences.com/irpass.asp?BzID=1109&amp;to=rl&amp;ResLibraryID=37833&amp;c=440&amp;l=1</guid><title><![CDATA[Derma Sciences Launches XTRASORB(TM) Foam Wound Dressing]]></title><pubDate>Tue, 4 May 2010 07:49:00 </pubDate><description><![CDATA[Product Line Extension Targets $300 Million Foam Wound Dressing MarketPRINCETON, N.J., May 4 /PRNewswire-FirstCall/ -- Derma Sciences, Inc. (Nasdaq: DSCI), a medical device and pharmaceutical company focused on advanced wound care, today announced the launch of its new XTRASORB&trade; Foam dressing.  The dressing is the company's first novel entry in the $300 million foam wound dressing market. First sales are expected during the second quarter of 2010.The majority of chronic wounds tend to...]]></description><link>http://www.ir.dermasciences.com/irpass.asp?BzID=1109&amp;to=rl&amp;ResLibraryID=37833&amp;c=440&amp;l=1</link></item><item><guid isPermaLink="true">http://www.ir.dermasciences.com/irpass.asp?BzID=1109&amp;to=rl&amp;ResLibraryID=37782&amp;c=440&amp;l=1</guid><title><![CDATA[Derma Sciences Announces First Quarter 2010 Results Conference Call]]></title><pubDate>Mon, 3 May 2010 09:33:00 </pubDate><description><![CDATA[PRINCETON, N.J., May 3 /PRNewswire-FirstCall/ -- Derma Sciences, Inc. (Nasdaq: DSCI), a specialty medical device/pharmaceutical company focused on advanced wound care, will hold a conference call on May 13, 2010 to discuss the results for the first quarter ended March 31, 2010. The conference call is scheduled to begin at 11:00 a.m. EDT (Eastern Daylight Time).  The results will be released at approximately 9:00 a.m. EDT that same day.To access the conference call, US-based listeners should...]]></description><link>http://www.ir.dermasciences.com/irpass.asp?BzID=1109&amp;to=rl&amp;ResLibraryID=37782&amp;c=440&amp;l=1</link></item><item><guid isPermaLink="true">http://www.ir.dermasciences.com/irpass.asp?BzID=1109&amp;to=rl&amp;ResLibraryID=37534&amp;c=440&amp;l=1</guid><title><![CDATA[Two Posters Featuring Derma Sciences' MEDIHONEY(R) Win Top Honors at American Professional Wound Care Association's 10th Annual Conference]]></title><pubDate>Tue, 20 Apr 2010 12:05:00 </pubDate><description><![CDATA[Investigators Debbie Segovia and Mary Webb Take First and Second Place in Poster Competition at ConferencePRINCETON, N.J., April 20 /PRNewswire-FirstCall/ -- Derma Sciences, Inc. (Nasdaq: DSCI), a specialty medical device/pharmaceutical company focused on advanced wound care, announced that two posters featuring MEDIHONEY&#174;, the company's honey-based dressings for the management of wounds and burns, took first and second place in a competition among more than 50 posters on display at the...]]></description><link>http://www.ir.dermasciences.com/irpass.asp?BzID=1109&amp;to=rl&amp;ResLibraryID=37534&amp;c=440&amp;l=1</link></item><item><guid isPermaLink="true">http://www.ir.dermasciences.com/irpass.asp?BzID=1109&amp;to=rl&amp;ResLibraryID=37498&amp;c=440&amp;l=1</guid><title><![CDATA[Derma Sciences, Inc. to Present at Taglich Brothers 7th Annual Small Cap Equity Conference]]></title><pubDate>Fri, 16 Apr 2010 13:15:00 </pubDate><description><![CDATA[http://media.marketwire.com/attachments/200604/255884_stacked-logo.gif -->http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=608769&amp;ProfileId=051205&amp;sourceType=1 -->NEW YORK, NY -- (Marketwire) -- 04/16/10 --    Taglich Brothers, Inc. is pleased to announce that Barry Wolfenson, Executive Vice President, Global Business Development/Marketing (NASDAQ: DSCI) will be presenting at our 7th Annual Small Cap Equity Conference May 4th, 2010. The Conference will take place at...]]></description><link>http://www.ir.dermasciences.com/irpass.asp?BzID=1109&amp;to=rl&amp;ResLibraryID=37498&amp;c=440&amp;l=1</link></item><item><guid isPermaLink="true">http://www.ir.dermasciences.com/irpass.asp?BzID=1109&amp;to=rl&amp;ResLibraryID=37271&amp;c=440&amp;l=1</guid><title><![CDATA[Derma Sciences' MEDIHONEY(R) to be Featured at American Professional Wound Care Association Conference]]></title><pubDate>Tue, 6 Apr 2010 07:15:00 </pubDate><description><![CDATA[Company Also To Present Posters Showcasing Successful MEDIHONEY(R) Case StudiesPRINCETON, N.J., April 6 /PRNewswire-FirstCall/ -- Derma Sciences, Inc. (Nasdaq: DSCI), a specialty medical device/pharmaceutical company focused on advanced wound care, announced today that the American Professional Wound Care Association plans to spotlight Derma's MEDIHONEY&#174; Wound and Burn Dressings at the Association's 10th Annual Conference, APWCA 2010, in Philadelphia this week. MEDIHONEY&#174; will be...]]></description><link>http://www.ir.dermasciences.com/irpass.asp?BzID=1109&amp;to=rl&amp;ResLibraryID=37271&amp;c=440&amp;l=1</link></item><item><guid isPermaLink="true">http://www.ir.dermasciences.com/irpass.asp?BzID=1109&amp;to=rl&amp;ResLibraryID=37227&amp;c=440&amp;l=1</guid><title><![CDATA[Derma Sciences Announces Fourth-Quarter and Full-Year 2009 Results]]></title><pubDate>Thu, 1 Apr 2010 07:15:00 </pubDate><description><![CDATA[PRINCETON, N.J., April 1 /PRNewswire-FirstCall/ -- Derma Sciences, Inc. (Nasdaq: DSCI), a specialty medical device/pharmaceutical company focused on advanced wound care, reported financial and operating results today for the three months and fiscal year ended December 31, 2009.Highlights for the three months ended December 31, 2009:Net sales increased 9% to $13,648,500 versus $12,558,067 in fourth quarter 2008.Advanced Wound Care sales increased 69% to $2,278,860 versus $1,348,734 in fourth...]]></description><link>http://www.ir.dermasciences.com/irpass.asp?BzID=1109&amp;to=rl&amp;ResLibraryID=37227&amp;c=440&amp;l=1</link></item><item><guid isPermaLink="true">http://www.ir.dermasciences.com/irpass.asp?BzID=1109&amp;to=rl&amp;ResLibraryID=36965&amp;c=440&amp;l=1</guid><title><![CDATA[Derma Sciences to Present at 2010 RedChip New York Equities Growth Conference]]></title><pubDate>Fri, 19 Mar 2010 07:13:00 </pubDate><description><![CDATA[Presentation Scheduled for March 23rd at 2:30 pm EDTPRINCETON, N.J., March 19 /PRNewswire-FirstCall/ -- Derma Sciences, Inc. (Nasdaq: DSCI), a specialty medical device/pharmaceutical company focused on advanced wound care, will present at the RedChip New York Equities Growth Conference on March 23, 2010 at 2:30 pm EDT.  The event will be held at the NASDAQ Market Site in New York City's Times Square.  Edward J. Quilty, CEO of Derma Sciences will provide attendees with an overview of the...]]></description><link>http://www.ir.dermasciences.com/irpass.asp?BzID=1109&amp;to=rl&amp;ResLibraryID=36965&amp;c=440&amp;l=1</link></item><item><guid isPermaLink="true">http://www.ir.dermasciences.com/irpass.asp?BzID=1109&amp;to=rl&amp;ResLibraryID=36609&amp;c=440&amp;l=1</guid><title><![CDATA[Derma Sciences Announces Fourth Quarter and Full Year 2009 Results Conference Call]]></title><pubDate>Thu, 4 Mar 2010 13:58:00 </pubDate><description><![CDATA[PRINCETON, N.J., March 4 /PRNewswire-FirstCall/ -- Derma Sciences, Inc. (Nasdaq: DSCI), a specialty medical device/pharmaceutical company focused on advanced wound care, will hold a conference call on April 1, 2010 to discuss the results for the fourth quarter and full year ended December 31, 2009. The conference call is scheduled to begin at 11:00 a.m. Eastern Daylight Time (EDT).  The results will be released at approximately 9:00 a.m. EDT that same day.To access the conference call, US-based...]]></description><link>http://www.ir.dermasciences.com/irpass.asp?BzID=1109&amp;to=rl&amp;ResLibraryID=36609&amp;c=440&amp;l=1</link></item><item><guid isPermaLink="true">http://www.ir.dermasciences.com/irpass.asp?BzID=1109&amp;to=rl&amp;ResLibraryID=36457&amp;c=440&amp;l=1</guid><title><![CDATA[Derma Sciences Finalizes Licensing Agreement for Worldwide Rights to MEDIHONEY(R)]]></title><pubDate>Thu, 25 Feb 2010 07:17:00 </pubDate><description><![CDATA[PRINCETON, N.J., Feb. 25 /PRNewswire-FirstCall/ -- Derma Sciences, Inc. (Nasdaq: DSCI), a specialty medical device/pharmaceutical company focused on advanced wound care, today announced that it has finalized a definitive set of agreements with Comvita New Zealand Ltd. (Comvita) of Paengaroa, New Zealand, giving Derma Sciences perpetual and exclusive worldwide licensing rights for MEDIHONEY&reg; professional wound care and skin products covering distribution and sales to all markets outside of...]]></description><link>http://www.ir.dermasciences.com/irpass.asp?BzID=1109&amp;to=rl&amp;ResLibraryID=36457&amp;c=440&amp;l=1</link></item><item><guid isPermaLink="true">http://www.ir.dermasciences.com/irpass.asp?BzID=1109&amp;to=rl&amp;ResLibraryID=36394&amp;c=440&amp;l=1</guid><title><![CDATA[Derma Sciences Gains Expanded Product Offering and Extended Contract Term for its BIOGUARD(TM) Dressing Line]]></title><pubDate>Tue, 23 Feb 2010 07:30:00 </pubDate><description><![CDATA[Strong Initial Sales Helps the Company Add Three Years to the Existing ContractPRINCETON, N.J., Feb. 23 /PRNewswire-FirstCall/ -- Derma Sciences, Inc. (Nasdaq: DSCI), a specialty medical device and pharmaceutical company focused on advanced wound care, today announced that it has successfully negotiated an additional three years on its current BIOGUARD&trade; licensing agreement with Quick-Med Technologies, Inc. (OTC Bulletin Board: QMDT).  This contract extension results in a potential 8-year...]]></description><link>http://www.ir.dermasciences.com/irpass.asp?BzID=1109&amp;to=rl&amp;ResLibraryID=36394&amp;c=440&amp;l=1</link></item><item><guid isPermaLink="true">http://www.ir.dermasciences.com/irpass.asp?BzID=1109&amp;to=rl&amp;ResLibraryID=36393&amp;c=440&amp;l=1</guid><title><![CDATA[Derma Sciences Announces Full Exercise of Over-Allotment Option and Closing of Public Equity Offering]]></title><pubDate>Tue, 23 Feb 2010 07:15:00 </pubDate><description><![CDATA[Company Raises $5.6 million in Gross ProceedsPRINCETON, N.J., Feb. 23 /PRNewswire-FirstCall/ -- Derma Sciences, Inc. (Nasdaq: DSCI), a specialty medical device/pharmaceutical company focused on advanced wound care, today announced that the underwriter of its recent public offering has exercised its over-allotment option, resulting in the issuance of an additional 145,800 shares and warrants to purchase 48,600 shares.  Derma Sciences closed its previously announced follow-on equity offering, for...]]></description><link>http://www.ir.dermasciences.com/irpass.asp?BzID=1109&amp;to=rl&amp;ResLibraryID=36393&amp;c=440&amp;l=1</link></item><item><guid isPermaLink="true">http://www.ir.dermasciences.com/irpass.asp?BzID=1109&amp;to=rl&amp;ResLibraryID=36266&amp;c=440&amp;l=1</guid><title><![CDATA[Derma Sciences Signs Contract With Leading Wound Care Company for Exclusive Distribution of BIOGUARD(TM) Barrier Dressings]]></title><pubDate>Thu, 18 Feb 2010 00:00:00 </pubDate><description><![CDATA[
Medline Industries gains exclusivity on sales of BIOGUARD into Acute Care

PRINCETON, N.J., Feb. 18 /PRNewswire-FirstCall/ -- Derma Sciences, Inc. (Nasdaq:DSCI - News), a specialty medical device and pharmaceutical company focused on advanced wound care, today announced that it has signed an exclusive distribution agreement with Medline Industries for sales of one of its key products – BIOGUARD™ Barrier Dressing – into the acute care market.  Medline is the 2nd leading provider of...]]></description><link>http://www.ir.dermasciences.com/irpass.asp?BzID=1109&amp;to=rl&amp;ResLibraryID=36266&amp;c=440&amp;l=1</link></item><item><guid isPermaLink="true">http://www.ir.dermasciences.com/irpass.asp?BzID=1109&amp;to=rl&amp;ResLibraryID=36267&amp;c=440&amp;l=1</guid><title><![CDATA[Derma Sciences Featured on NJN News and WNET 13
]]></title><pubDate>Thu, 18 Feb 2010 00:00:00 </pubDate><description><![CDATA[

PRINCETON, N.J., Feb. 18 /PRNewswire-FirstCall/ -- Derma Sciences, Inc. (Nasdaq:DSCI - News), a specialty medical device/pharmaceutical company focused on advanced wound care, was featured on NJN News on February 16, 2010.  The segment ran during the NJN Nightly News broadcast at 6:00 pm, 7:30 pm and 11:00 pm.  It also aired on WNET Channel 13 in New York City at 5:30 pm.  
NJN health reporter Sara Lee Kessler reported on how the medical-grade honey known as Leptospermum honey, native to...]]></description><link>http://www.ir.dermasciences.com/irpass.asp?BzID=1109&amp;to=rl&amp;ResLibraryID=36267&amp;c=440&amp;l=1</link></item><item><guid isPermaLink="true">http://www.ir.dermasciences.com/irpass.asp?BzID=1109&amp;to=rl&amp;ResLibraryID=36228&amp;c=440&amp;l=1</guid><title><![CDATA[Derma Sciences Announces Pricing of Follow-on Offering]]></title><pubDate>Wed, 17 Feb 2010 00:00:00 </pubDate><description><![CDATA[
PRINCETON, N.J., Feb. 17 /PRNewswire-FirstCall/ -- Derma Sciences, Inc. (Nasdaq:DSCI - News), a specialty medical device and pharmaceutical company focused on advanced wound care, today announced the pricing of a public offering of 972,000 shares of DSCI common stock and 324,000 warrants to purchase shares of common stock at a price of $5.50. Each share, together with a warrant to purchase one-third of a share, was priced at $5.00. The Company has granted the underwriters a 45-day option to...]]></description><link>http://www.ir.dermasciences.com/irpass.asp?BzID=1109&amp;to=rl&amp;ResLibraryID=36228&amp;c=440&amp;l=1</link></item><item><guid isPermaLink="true">http://www.ir.dermasciences.com/irpass.asp?BzID=1109&amp;to=rl&amp;ResLibraryID=36095&amp;c=440&amp;l=1</guid><title><![CDATA[Derma Sciences, Inc. to List Its Common Stock on NASDAQ]]></title><pubDate>Tue, 9 Feb 2010 00:00:00 </pubDate><description><![CDATA[

PRINCETON, N.J. -- Derma Sciences, Inc. (OTC Bulletin Board: DSCID), a specialty medical device/pharmaceutical company focused on advanced wound care, will list its common stock on the NASDAQ Capital Market effective February 10, 2010 under the ticker symbol "DSCI".


"The NASDAQ listing represents a significant step for Derma Sciences that will provide increased visibility and should result in improved liquidity for our shares," said CEO Ed Quilty.
About Derma Sciences, Inc.
Derma...]]></description><link>http://www.ir.dermasciences.com/irpass.asp?BzID=1109&amp;to=rl&amp;ResLibraryID=36095&amp;c=440&amp;l=1</link></item><item><guid isPermaLink="true">http://www.ir.dermasciences.com/irpass.asp?BzID=1109&amp;to=rl&amp;ResLibraryID=35838&amp;c=440&amp;l=1</guid><title><![CDATA[Derma Sciences Announces 8-for-1 Reverse Stock Split]]></title><pubDate>Fri, 29 Jan 2010 00:00:00 </pubDate><description><![CDATA[Split is effective Monday, February 1, 2010
 
PRINCETON, N.J., Jan. 29 /PRNewswire-FirstCall/ -- Derma Sciences, Inc. (OTC Bulletin Board: DSCI), a specialty medical device/pharmaceutical company focused on advanced wound care, today announced that it would implement an 8-for-1 reverse split of its issued and outstanding common shares, effective for shareholders of record on February 1, 2010, and a proportional reduction of its authorized common and preferred shares. Immediately after the...]]></description><link>http://www.ir.dermasciences.com/irpass.asp?BzID=1109&amp;to=rl&amp;ResLibraryID=35838&amp;c=440&amp;l=1</link></item><item><guid isPermaLink="true">http://www.ir.dermasciences.com/irpass.asp?BzID=1109&amp;to=rl&amp;ResLibraryID=36331&amp;c=440&amp;l=1</guid><title><![CDATA[Derma Sciences Signs Three-Year Contract With Leading Global Healthcare Company]]></title><pubDate>Tue, 5 Jan 2010 00:00:00 </pubDate><description><![CDATA[
Agreement Will Generate $15 Million in Revenue for Derma Sciences Beginning In 2010 

PRINCETON, N.J., Jan. 5 /PRNewswire-FirstCall/ -- Derma Sciences, Inc.  (OTC Bulletin Board: DSCI), a specialty medical device/pharmaceutical company focused on advanced wound care, has finalized a contract with a leading global healthcare products company to produce finger bandages.  The agreement is expected to generate a total of approximately $15 million in new revenue for Derma Sciences over a...]]></description><link>http://www.ir.dermasciences.com/irpass.asp?BzID=1109&amp;to=rl&amp;ResLibraryID=36331&amp;c=440&amp;l=1</link></item><item><guid isPermaLink="true">http://www.ir.dermasciences.com/irpass.asp?BzID=1109&amp;to=rl&amp;ResLibraryID=35161&amp;c=440&amp;l=1</guid><title><![CDATA[Derma Sciences Obtains Exclusive Worldwide Rights to MEDIHONEY(R)]]></title><pubDate>Tue, 22 Dec 2009 00:00:00 </pubDate><description><![CDATA[
Comvita Grants Perpetual Rights To This Highly Successful Wound Care Dressing For Medical And Professional Markets
Agreement Greatly Expands MEDIHONEY(R) Customer Base



PRINCETON, N.J., Dec. 22 /PRNewswire-FirstCall/ -- Derma Sciences, Inc. (OTC Bulletin Board: DSCI), a specialty medical device and pharmaceutical company focused on advanced wound care, today announced that it has completed a comprehensive Heads of Agreement with Comvita New Zealand Ltd. (Comvita) of Paengaroa, New...]]></description><link>http://www.ir.dermasciences.com/irpass.asp?BzID=1109&amp;to=rl&amp;ResLibraryID=35161&amp;c=440&amp;l=1</link></item><item><guid isPermaLink="true">http://www.ir.dermasciences.com/irpass.asp?BzID=1109&amp;to=rl&amp;ResLibraryID=34981&amp;c=440&amp;l=1</guid><title><![CDATA[Derma Sciences' Bioguard Gauze Dressings May Provide Safeguards Against Influenza Viruses]]></title><pubDate>Wed, 9 Dec 2009 00:00:00 </pubDate><description><![CDATA[
Independent Lab Report Shows Greater Than 99.9% Inactivation Rates against Swine Flu Virus after 24 Hours' Exposure to Barrier Gauze Dressing


PRINCETON, N.J., Dec. 9 /PRNewswire-FirstCall/ -- Derma Sciences, Inc. (OTC Bulletin Board: DSCI), a specialty medical device and pharmaceutical company focused on advanced wound care, today released an independent laboratory report indicating that the company's BIOGUARD barrier gauze dressings exhibit high antiviral efficacy against the H1N1...]]></description><link>http://www.ir.dermasciences.com/irpass.asp?BzID=1109&amp;to=rl&amp;ResLibraryID=34981&amp;c=440&amp;l=1</link></item><item><guid isPermaLink="true">http://www.ir.dermasciences.com/irpass.asp?BzID=1109&amp;to=rl&amp;ResLibraryID=34655&amp;c=440&amp;l=1</guid><title><![CDATA[Derma Sciences Reports Third Quarter 2009 Results]]></title><pubDate>Mon, 16 Nov 2009 00:00:00 </pubDate><description><![CDATA[
Significant Quarter-over-Quarter Improvement Enables Company to Achieve Profitability

Conference Call Scheduled for 11 am Today

PRINCETON, N.J., Nov. 16 /PRNewswire-FirstCall/ -- Derma Sciences, Inc. (OTC Bulletin Board: DSCI) a specialty medical device / pharmaceutical company focused on advanced wound care, reported financial and operating results today for the three months and nine months ended September 30, 2009.
Highlights for the three months ended September 30, 2009:

    Net...]]></description><link>http://www.ir.dermasciences.com/irpass.asp?BzID=1109&amp;to=rl&amp;ResLibraryID=34655&amp;c=440&amp;l=1</link></item><item><guid isPermaLink="true">http://www.ir.dermasciences.com/irpass.asp?BzID=1109&amp;to=rl&amp;ResLibraryID=34656&amp;c=440&amp;l=1</guid><title><![CDATA[Derma Sciences Files S-1 Registration Statement]]></title><pubDate>Mon, 16 Nov 2009 00:00:00 </pubDate><description><![CDATA[
Company to Offer 1,500,000 Shares in Recapitalization, Secure NASDAQ Listing

Rodman &amp; Renshaw to Underwrite Follow-on Offering

PRINCETON, N.J., Nov. 16 /PRNewswire-FirstCall/ -- Derma Sciences, Inc. (OTC Bulletin Board: DSCI) a specialty medical device/pharmaceutical company focused on advanced wound care, announced today that it has filed an S-1 Registration Statement to offer 1,500,000 shares of its common stock. Rodman &amp; Renshaw, LLC, a subsidiary of Rodman &amp; Renshaw...]]></description><link>http://www.ir.dermasciences.com/irpass.asp?BzID=1109&amp;to=rl&amp;ResLibraryID=34656&amp;c=440&amp;l=1</link></item><item><guid isPermaLink="true">http://www.ir.dermasciences.com/irpass.asp?BzID=1109&amp;to=rl&amp;ResLibraryID=33964&amp;c=440&amp;l=1</guid><title><![CDATA[Derma Sciences Announces Date of Its Third Quarter 2009 Earnings Release and Conference Call]]></title><pubDate>Fri, 6 Nov 2009 06:47:00 </pubDate><description><![CDATA[PRINCETON, N.J., Nov. 6 /PRNewswire-FirstCall/ -- Derma Sciences, Inc. (OTC Bulletin Board: DSCI), a provider of advanced wound care products, announced plans to release its third quarter 2009 results before market on Monday, November 16, 2009. The Company will hold a conference call that same day to discuss the results at 11:00 am EST. Interested parties should call (866) 788-0546 (domestic) or (857) 350-1684 (international), with passcode 81416481 to access the call. You may also access this...]]></description><link>http://www.ir.dermasciences.com/irpass.asp?BzID=1109&amp;to=rl&amp;ResLibraryID=33964&amp;c=440&amp;l=1</link></item><item><guid isPermaLink="true">http://www.ir.dermasciences.com/irpass.asp?BzID=1109&amp;to=rl&amp;ResLibraryID=32169&amp;c=440&amp;l=1</guid><title><![CDATA[Derma Sciences To Present at Rodman &amp; Renshaw's Eleventh Annual Healthcare Conference]]></title><pubDate>Wed, 2 Sep 2009 08:45:00 </pubDate><description><![CDATA[September 11, 2009, New York Palace HotelPRINCETON, N.J., Sept. 2 /PRNewswire-FirstCall/ -- Derma Sciences, Inc. (OTC Bulletin Board: DSCI), a provider of advanced wound care products, will present at Rodman &amp; Renshaw's Eleventh Annual Healthcare Conferencetaking place September 9 - 11, 2009, at the New York Palace Hotel. Edward J. Quilty, Chairman and Chief Executive Officer will give the company presentation on Friday, September 11, 2009, 9:10AM EDT in the Fahnestock Salon (fifth floor)....]]></description><link>http://www.ir.dermasciences.com/irpass.asp?BzID=1109&amp;to=rl&amp;ResLibraryID=32169&amp;c=440&amp;l=1</link></item><item><guid isPermaLink="true">http://www.ir.dermasciences.com/irpass.asp?BzID=1109&amp;to=rl&amp;ResLibraryID=31958&amp;c=440&amp;l=1</guid><title><![CDATA[Derma Sciences Reports Second Quarter 2009 Results]]></title><pubDate>Mon, 17 Aug 2009 07:00:00 </pubDate><description><![CDATA[Highlights Include: MEDIHONEY(R) Sales Increased 125% Year-Over-Year; Gross Profit Margin Increased to 29.6%; Cash Flow is Significantly ImprovingPRINCETON, N.J., Aug. 17 /PRNewswire-FirstCall/ -- Derma Sciences, Inc. (OTC Bulletin Board: DSCI), a provider of advanced wound care products, reports results today for the second quarter and six months ended June 30, 2009.Highlights for second quarter and six months ended June 30, 2009:
    --  Gross U.S. MEDIHONEY(R) sales increased $394,451, or...]]></description><link>http://www.ir.dermasciences.com/irpass.asp?BzID=1109&amp;to=rl&amp;ResLibraryID=31958&amp;c=440&amp;l=1</link></item><item><guid isPermaLink="true">http://www.ir.dermasciences.com/irpass.asp?BzID=1109&amp;to=rl&amp;ResLibraryID=31853&amp;c=440&amp;l=1</guid><title><![CDATA[Derma Sciences Announces Date of Its Second Quarter 2009 Earnings Release and Conference Call]]></title><pubDate>Mon, 10 Aug 2009 09:00:00 </pubDate><description><![CDATA[PRINCETON, N.J., Aug. 10 /PRNewswire-FirstCall/ -- Derma Sciences, Inc. (OTC Bulletin Board: DSCI), a provider of advanced wound care products, announced plans to release its second quarter 2009 results before market on Monday, August 17, 2009. The Company will hold a conference call that same day to discuss the results at 11:00 am EDT. Interested parties should call 866-383-8108 (domestic) or 617-597-5343 (international), with passcode 38260746 to access the call. You may also access this call...]]></description><link>http://www.ir.dermasciences.com/irpass.asp?BzID=1109&amp;to=rl&amp;ResLibraryID=31853&amp;c=440&amp;l=1</link></item><item><guid isPermaLink="true">http://www.ir.dermasciences.com/irpass.asp?BzID=1109&amp;to=rl&amp;ResLibraryID=30862&amp;c=440&amp;l=1</guid><title><![CDATA[Derma Sciences Announces First Commercial Sales of BIOGUARD(TM) Barrier Dressings]]></title><pubDate>Tue, 23 Jun 2009 09:28:00 </pubDate><description><![CDATA[PRINCETON, N.J., June 23 /PRNewswire-FirstCall/ -- Derma Sciences, Inc. (OTC Bulletin Board: DSCI), a provider of advanced wound care products, announced today that it has begun shipping BIOGUARD(TM) Barrier Dressings to customers.  Separately, the company announced that it has been awarded reimbursement codes for the dressings, allowing the products to be reimbursable by Medicare.  BIOGUARD will offer surgeons, wound care clinicians, infection control experts and primary care doctors a new...]]></description><link>http://www.ir.dermasciences.com/irpass.asp?BzID=1109&amp;to=rl&amp;ResLibraryID=30862&amp;c=440&amp;l=1</link></item><item><guid isPermaLink="true">http://www.ir.dermasciences.com/irpass.asp?BzID=1109&amp;to=rl&amp;ResLibraryID=30338&amp;c=440&amp;l=1</guid><title><![CDATA[Derma Sciences Reports First Quarter 2009 Results]]></title><pubDate>Mon, 18 May 2009 07:30:00 </pubDate><description><![CDATA[PRINCETON, N.J., May 18 /PRNewswire-FirstCall/ -- Derma Sciences, Inc. (OTC Bulletin Board: DSCI), a provider of advanced wound care products, announced results today for the first quarter ended March 31, 2009.  For the quarter, the Company reported net sales of $10.4 million versus $11.7 million in the first quarter 2008. The sales decrease of $1.3 million was principally attributable to foreign exchange associated with a significant weakening in the Canadian dollar and inventory...]]></description><link>http://www.ir.dermasciences.com/irpass.asp?BzID=1109&amp;to=rl&amp;ResLibraryID=30338&amp;c=440&amp;l=1</link></item><item><guid isPermaLink="true">http://www.ir.dermasciences.com/irpass.asp?BzID=1109&amp;to=rl&amp;ResLibraryID=30035&amp;c=440&amp;l=1</guid><title><![CDATA[Derma Sciences Announces Date of Its First Quarter 2009 Earnings Release and Conference Call]]></title><pubDate>Mon, 11 May 2009 11:56:00 </pubDate><description><![CDATA[PRINCETON, N.J., May 11 /PRNewswire-FirstCall/ -- Derma Sciences, Inc. (OTC Bulletin Board: DSCI), a provider of advanced wound care products, announced plans to release its first quarter 2009 results before market on Monday, May 18, 2009.  The Company will hold a conference call that same day to discuss the results at 11:00 am EDT. Interested parties should call 800-299-8538 (domestic) or 617-786-2902 (international), with passcode 98098954 to access the call. You may also access this call via...]]></description><link>http://www.ir.dermasciences.com/irpass.asp?BzID=1109&amp;to=rl&amp;ResLibraryID=30035&amp;c=440&amp;l=1</link></item><item><guid isPermaLink="true">http://www.ir.dermasciences.com/irpass.asp?BzID=1109&amp;to=rl&amp;ResLibraryID=29947&amp;c=440&amp;l=1</guid><title><![CDATA[Derma Sciences Announces New Contract With Major Medical Products Supplier for Private Label Adhesive Bandages]]></title><pubDate>Wed, 6 May 2009 11:24:00 </pubDate><description><![CDATA[Contract's Annual Value Estimated to Range from $1.5 Million-$3 MillionPRINCETON, N.J., May 6 /PRNewswire-FirstCall/ -- Derma Sciences (OTC Bulletin Board: DSCI), a manufacturer and marketer of advanced wound care products, today announced it has signed a new contract to supply private label adhesive bandages to one of the largest medical supply companies in the U.S. Annual revenues under the contract are expected to range between $1.5 to $3.0 million for Derma Sciences.  Shipments to the...]]></description><link>http://www.ir.dermasciences.com/irpass.asp?BzID=1109&amp;to=rl&amp;ResLibraryID=29947&amp;c=440&amp;l=1</link></item><item><guid isPermaLink="true">http://www.ir.dermasciences.com/irpass.asp?BzID=1109&amp;to=rl&amp;ResLibraryID=29925&amp;c=440&amp;l=1</guid><title><![CDATA[Derma Sciences Announces Voluntary Delisting from the Defunct Boston Stock Exchange]]></title><pubDate>Tue, 5 May 2009 17:12:00 </pubDate><description><![CDATA[PRINCETON, N.J., May 5 /PRNewswire-FirstCall/ -- Derma Sciences (OTC Bulletin Board: DSCI), a manufacturer and marketer of advanced wound care products, today announced that it intended to voluntarily delist its common stock, $0.01 par value, from the defunct Boston Stock Exchange and that it would file Form 25 with the Securities and Exchange Commission on or about May 15, 2009 to effect this delisting.Ed Quilty, CEO of Derma Sciences, noted that, "In October, 2007 Nasdaq acquired the Boston...]]></description><link>http://www.ir.dermasciences.com/irpass.asp?BzID=1109&amp;to=rl&amp;ResLibraryID=29925&amp;c=440&amp;l=1</link></item><item><guid isPermaLink="true">http://www.ir.dermasciences.com/irpass.asp?BzID=1109&amp;to=rl&amp;ResLibraryID=29817&amp;c=440&amp;l=1</guid><title><![CDATA[Clinician Reports Fast Healing of Intractable Wounds Using MEDIHONEY(R)]]></title><pubDate>Wed, 29 Apr 2009 14:23:00 </pubDate><description><![CDATA[Jason Hanft of Baptist Health South Florida Reports on 11 Patients at SAWCPRINCETON, N.J., April 29/PRNewswire-FirstCall/ --Derma Sciences (OTC Bulletin Board: DSCI), a provider of advanced wound care products, announced that yesterday at the annual Symposium on the Advances in Wound Care (SAWC) in Dallas, Jason R. Hanft, DPM, Director of Medical Education at Baptist Health South Florida, revealed details of a recently concluded 11-patient venous leg ulcer (VLU) case series involving the use of...]]></description><link>http://www.ir.dermasciences.com/irpass.asp?BzID=1109&amp;to=rl&amp;ResLibraryID=29817&amp;c=440&amp;l=1</link></item><item><guid isPermaLink="true">http://www.ir.dermasciences.com/irpass.asp?BzID=1109&amp;to=rl&amp;ResLibraryID=29269&amp;c=440&amp;l=1</guid><title><![CDATA[Derma Sciences Reports Fourth Quarter, Year-End Results for 2008]]></title><pubDate>Wed, 1 Apr 2009 07:30:00 </pubDate><description><![CDATA[PRINCETON, N.J., April 1 /PRNewswire-FirstCall/ --Derma Sciences, Inc. (OTC Bulletin Board: DSCI), a provider of advanced wound care products, reported that sales for 2008 rose 47.1% year-over-year, reflecting incremental sales from its First Aid Division (FAD) and higher sales of proprietary advanced wound care products led by MEDIHONEY(R).  Sales for the year were $50.2 million vs $34.1 million in 2007. The Company's loss increased consistent with expectations to $4.0 million or $0.10 per...]]></description><link>http://www.ir.dermasciences.com/irpass.asp?BzID=1109&amp;to=rl&amp;ResLibraryID=29269&amp;c=440&amp;l=1</link></item><item><guid isPermaLink="true">http://www.ir.dermasciences.com/irpass.asp?BzID=1109&amp;to=rl&amp;ResLibraryID=29152&amp;c=440&amp;l=1</guid><title><![CDATA[Derma Sciences to Report 2008 Fourth Quarter and Year-End Results on April 1, 2009]]></title><pubDate>Tue, 24 Mar 2009 07:30:00 </pubDate><description><![CDATA[PRINCETON, N.J., March 24 /PRNewswire-FirstCall/ -- Derma Sciences, Inc. (OTC Bulletin Board: DSCI), a provider of advanced wound care products, announced today that it will report its fourth quarter and year-end 2008 results on Wednesday, April 1, 2009.  The Company will hold a conference call that same day to discuss the results at 11:00 am EDT. Interested parties should call 866-271-5140 (domestic) or 617-213-8893 (international), with passcode 42480759 to access the call. You may also...]]></description><link>http://www.ir.dermasciences.com/irpass.asp?BzID=1109&amp;to=rl&amp;ResLibraryID=29152&amp;c=440&amp;l=1</link></item><item><guid isPermaLink="true">http://www.ir.dermasciences.com/irpass.asp?BzID=1109&amp;to=rl&amp;ResLibraryID=28645&amp;c=440&amp;l=1</guid><title><![CDATA[Derma Sciences Gains FDA Clearance for Novel BIOGUARD(TM) Barrier Dressing with NIMBUS(R) Technology]]></title><pubDate>Fri, 27 Feb 2009 07:30:00 </pubDate><description><![CDATA[Dressing Offers a Highly Effective and Affordable New Option to Help Combat the Escalating MRSA CrisisPRINCETON, N.J., Feb. 27 /PRNewswire-FirstCall/ --Derma Sciences, Inc. (OTC Bulletin Board: DSCI), a provider of advanced wound care products, announced today that its first BIOGUARD Barrier Dressings have received clearance from the U.S. Food and Drug Administration for marketing and distribution.  BIOGUARD will offer surgeons, wound care clinicians, infection control experts and primary care...]]></description><link>http://www.ir.dermasciences.com/irpass.asp?BzID=1109&amp;to=rl&amp;ResLibraryID=28645&amp;c=440&amp;l=1</link></item><item><guid isPermaLink="true">http://www.ir.dermasciences.com/irpass.asp?BzID=1109&amp;to=rl&amp;ResLibraryID=28426&amp;c=440&amp;l=1</guid><title><![CDATA[MEDIHONEY(TM) Dressings Shown to Help Improve Outcomes of Non-Healing Venous Leg Ulcers in Recent Case Series]]></title><pubDate>Fri, 13 Feb 2009 00:00:00 </pubDate><description><![CDATA[


 
Eleven of eleven wounds healed in 6 weeks or less
 
PRINCETON, N.J., Feb. 13 /PRNewswire-FirstCall/ -- Derma Sciences, Inc. (OTC Bulletin Board: DSCI), a provider of advanced wound care products, announced today that its MEDIHONEY Dressings were the focus of a case series on eleven non-healing venous leg ulcers. These wounds had previously failed to heal while being managed with such therapeutic modalities as multi-layered compression, silver antimicrobial dressings, antibiotic...]]></description><link>http://www.ir.dermasciences.com/irpass.asp?BzID=1109&amp;to=rl&amp;ResLibraryID=28426&amp;c=440&amp;l=1</link></item><item><guid isPermaLink="true">http://www.ir.dermasciences.com/irpass.asp?BzID=1109&amp;to=rl&amp;ResLibraryID=28024&amp;c=440&amp;l=1</guid><title><![CDATA[MEDIHONEY Used to Prevent Amputation of Patient's Leg]]></title><pubDate>Tue, 13 Jan 2009 09:48:00 </pubDate><description><![CDATA[Clinicians at major NY hospital tout MEDIHONEY(TM) at press conferencePRINCETON, N.J., Jan. 13 /PRNewswire-FirstCall/ -- Derma Sciences, Inc. (OTC Bulletin Board: DSCI), a provider of advanced wound care products, announced today that MEDIHONEY was the focus of a major press conference last week at North Shore Long Island Jewish Hospital in Manhasset, NY.  At the press conference, clinicians detailed the case of a patient who appeared to be heading towards a lower extremity amputation (LEA) due...]]></description><link>http://www.ir.dermasciences.com/irpass.asp?BzID=1109&amp;to=rl&amp;ResLibraryID=28024&amp;c=440&amp;l=1</link></item><item><guid isPermaLink="true">http://www.ir.dermasciences.com/irpass.asp?BzID=1109&amp;to=rl&amp;ResLibraryID=27510&amp;c=440&amp;l=1</guid><title><![CDATA[Derma Sciences Reports Third Quarter 2008 Results]]></title><pubDate>Mon, 17 Nov 2008 07:30:00 </pubDate><description><![CDATA[PRINCETON, N.J., Nov. 17 /PRNewswire-FirstCall/ -- Derma Sciences, Inc.
(OTC Bulletin Board: DSCI), a provider of advanced wound care products,
announced results today for the third quarter and first nine months ended
September 30, 2008. Revenues for the quarter were $12,832,574, an increase of
59% over the $8,056,402 in revenues recorded during the same period last year.
The results include nine months of sales from our First Aid Division (FAD)
acquired in November 2007 and solid growth from...]]></description><link>http://www.ir.dermasciences.com/irpass.asp?BzID=1109&amp;to=rl&amp;ResLibraryID=27510&amp;c=440&amp;l=1</link></item><item><guid isPermaLink="true">http://www.ir.dermasciences.com/irpass.asp?BzID=1109&amp;to=rl&amp;ResLibraryID=27430&amp;c=440&amp;l=1</guid><title><![CDATA[Derma Sciences Announces Date of Its Third Quarter 2008 Earnings Release and Conference Call]]></title><pubDate>Mon, 10 Nov 2008 00:00:00 </pubDate><description><![CDATA[
PRINCETON, N.J., Nov. 10 /PRNewswire-FirstCall/ -- Derma Sciences, Inc. (OTC Bulletin Board: DSCI), provider of advanced wound care products, announced plans to release its third quarter 2008 results before market on Monday, November 17, 2008. The Company will hold a conference call that same day to discuss the results at 11:00 am EST. Interested parties should call 800 299 0433 (domestic) or 617 801 9712 (international), with passcode 96313249 to access the call. You may also access this...]]></description><link>http://www.ir.dermasciences.com/irpass.asp?BzID=1109&amp;to=rl&amp;ResLibraryID=27430&amp;c=440&amp;l=1</link></item></channel></rss>